Sequence information
Variant position: 356 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 860 The length of the canonical sequence.
Location on the sequence:
YECLCPDGFQLVAQRRCEDI
D ECQDPDTCSQLCVNLEGGYK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human YECLCPDGFQLVAQRRCEDID ECQDPDTCSQLCVNLEGGYK
Mouse SECLCPSGFRLVDLHRCEDID ECQEPDTCSQLCVNLEGSYK
Rat YECLCPSGFRLVDGHQCEDID ECQEPDTCSQLCVNLEGSFK
Bovine YECLCPEGFQLVGKHRCEDID ECQNPDTCSQLCVNLEGSYK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
22 – 860
Low-density lipoprotein receptor
Topological domain
22 – 788
Extracellular
Domain
354 – 393
EGF-like 2; calcium-binding
Literature citations
Molecular genetics of familial hypercholesterolaemia in Norway.
Leren T.P.; Tonstad S.; Gundersen K.E.; Bakken K.S.; Rodningen O.K.; Sundvold H.; Ose L.; Berg K.;
J. Intern. Med. 241:185-194(1997)
Cited for: VARIANTS FHCL1 PRO-56; TYR-175; TYR-356; VAL-401 AND TRP-416;
The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.
Abifadel M.; Rabes J.-P.; Jambart S.; Halaby G.; Gannage-Yared M.-H.; Sarkis A.; Beaino G.; Varret M.; Salem N.; Corbani S.; Aydenian H.; Junien C.; Munnich A.; Boileau C.;
Hum. Mutat. 30:E682-E691(2009)
Cited for: VARIANTS FHCL1 PRO-254; TYR-356; TYR-358; THR-451 AND SER-826;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.